Conclusion
The use of digoxin has been limited because the agent has a narrow therapeutic index and requires close monitoring. Digoxin can lead to many AEs and has multiple drug interactions. Despite its limitations, digoxin still has a place in therapy for HF, AF, and numerous off-label uses. It is considered adjunctive therapy, rather than first-line therapy.